CAC Nantong Chemical Co.,Ltd.
announced that it was awarded a new patent in the European Union, EU, for one of its key product, Azoxystrobin.
The patent is related to a new manufacturing process for Azoxystrobin, which can significantly increase product quality and production yield, while reducing waste generated during manufacturing.
The approval of the patent in the EU is part of the global patent structure of CAC Nantong. This patent has already been granted by five countries, which are China, the US, Australia, South Africa and Ukraine.
CAC Nantong has always stood for innovation and the protection of intellectual property rights, and has kept investing in independent innovation in intellectual property for many years. The independent IP office at CAC Nantong is dedicated to studying patents and IP protection, and is involved in all new internal product development from the starting stage of each project. The office will draft a clear FTO strategy for all potential products in the R&D pipeline, enabling the company to participate effectively in the off-patent market.
CAC Nantong and its affiliates have applied for over 300 patents in several countries over the last several years, and over 100 of them have been granted.
Respecting intellectual property rights guarantees the healthy and stable development of the chemical industry and protects innovation. Currently, the international trading business environment is becoming increasingly complex. CAC Nantong, as a professional supplier of agrochemicals, has made IP and innovation its strategic policy, which will help it and its partners achieve long-term, healthy and stable development.
As well as the EU, CAC Nantong also filed patents in all major Azoxystrobin markets, including Brazil, Argentina, Japan, Korea, Israel, Canada, India, Vietnam and New Zealand. These applications are still in process.